Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
576.00    -1.00 (-0.17%)
Bid:
575.00
Ask:
578.00
Spread: 3.00 (0.522%)
Market Cap: £501.84m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

18 Dec 2018 15:19

RNS Number : 8757K
Victrex PLC
18 December 2018
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Tim Cooper

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Victrex plc

b)

 

LEI

 

 

213800UYNPHAUNHPXL67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB0009292243

b)

 

Nature of the transaction

 

 

Exercise of 1,012 nil cost options granted 15 December 2014 under the Victrex plc 2009 Long Term Incentive Plan.

 

Sold sufficient shares arising from the transaction to cover costs and tax and retained the balance as shares.

 

In respect of the net hypothetical dividend on the vested shares Mr Cooper received an additional 78 shares at £21.38.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s) sold

Volume retained

£21.38

478

534

£21.38

Nil

78

d)

 

Aggregated information

- Aggregated volume exercised

- No of shares retained

1,012

534 + 78 = 612

- Price

£21.38

e)

 

Date of the transaction

 

 

2018-12-17

f)

 

Place of the transaction

 

 

Thornton, Cleveleys, Lancashire,

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Martin Court

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Victrex plc

b)

 

LEI

 

 

213800UYNPHAUNHPXL67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB0009292243

b)

 

Nature of the transaction

 

 

Exercise and hold of 934 nil cost options granted 15 December 2014 under the Victrex plc 2009 Long Term Incentive Plan.

 

In respect of the gross hypothetical dividend on the vested shares Dr Court received an additional 136 shares at £21.38.

 

Dr Court has elected to self fund any tax liability arising from the transaction and therefore no sale of shares was required to cover costs.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s) sold

Volume retained

N/A

Nil

934

£21.38

Nil

136

d)

 

Aggregated information

- Aggregated volume exercised

- No of shares retained

934

934 + 136 = 1,070

- Price

N/A

 

£21.38 (for 136)

e)

 

Date of the transaction

 

 

2018-12-17

f)

 

Place of the transaction

 

 

Thornton, Cleveleys, Lancashire,

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Martin Court

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Victrex plc

b)

 

LEI

 

 

213800UYNPHAUNHPXL67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB0009292243

b)

 

Nature of the transaction

 

 

Exercise of 3,686 nil cost options granted 14 December 2015 under the Victrex plc 2009 Long Term Incentive Plan.

 

Sold sufficient shares arising from the exercise to cover costs and tax and retained the balance as shares.

 

In respect of the gross hypothetical dividend on the vested shares, Dr Court received an additional 359 shares at £22.28.

 

Dr Court has elected to self fund any tax liability arising from the hypothetical dividend.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s) sold

Volume retained

£21.38

1,739

1,947

£22.28

Nil

359

d)

 

Aggregated information

- Aggregated volume exercised

- No of shares retained

3,686

1,947 + 359 = 2,306

- Price

£21.38 (for 1,947) and £22.28 (for 359)

e)

 

Date of the transaction

 

 

2018-12-17

f)

 

Place of the transaction

 

 

Thornton, Cleveleys, Lancashire,

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMMMZKRNGRZM
Date   Source Headline
30th Jun 20251:38 pmRNSTotal Voting Rights
30th Jun 20259:13 amRNSDirector Declaration
18th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jun 20251:56 pmRNSHolding(s) in Company
2nd Jun 202511:34 amRNSBlock listing Interim Review
2nd Jun 202510:25 amRNSHolding(s) in Company
30th May 20259:50 amRNSTotal Voting Rights
27th May 202512:40 pmRNSHolding(s) in Company
13th May 20253:30 pmRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSVictrex plc – Interim Results 2025
7th May 20257:00 amRNS‘Magma’ advances via TechnipFMC award
30th Apr 202511:00 amRNSTotal Voting Rights
31st Mar 20259:17 amRNSTotal Voting Rights
21st Mar 202510:34 amRNSDirector/PDMR Shareholding
28th Feb 20259:55 amRNSTotal Voting Rights
19th Feb 20259:00 amRNSAdditional Listing
7th Feb 20251:54 pmRNSResult of AGM
7th Feb 20257:00 amRNSAGM and Trading Update
31st Jan 20259:17 amRNSTotal Voting Rights
21st Jan 20251:56 pmRNSHolding(s) in Company
6th Jan 20251:00 pmRNSAnnual Financial Report
31st Dec 20249:00 amRNSTotal Voting Rights
16th Dec 20248:52 amRNSDirector/PDMR Shareholding
11th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 202411:46 amRNSDirector/PDMR Shareholding
10th Dec 20249:28 amRNSHolding(s) in Company
3rd Dec 202410:58 amRNSDirector/PDMR Shareholding
3rd Dec 20247:00 amRNSVictrex plc - Preliminary Results 2024
2nd Dec 20249:38 amRNSBlock listing Interim Review
29th Nov 20249:07 amRNSTotal Voting Rights
14th Nov 20249:31 amRNSHolding(s) in Company
31st Oct 202412:25 pmRNSTotal Voting Rights
14th Oct 20243:09 pmRNSHolding(s) in Company
30th Sep 20241:44 pmRNSTotal Voting Rights
27th Sep 20249:22 amRNSHolding(s) in Company
24th Sep 202411:24 amRNSDirector/PDMR Shareholding
17th Sep 20242:00 pmRNSUS FDA approval: Total Knee Study
12th Sep 202411:18 amRNSDirector/PDMR Shareholding
3rd Sep 20244:20 pmRNSHolding(s) in Company
30th Aug 20243:44 pmRNSDirector/PDMR Shareholding
30th Aug 20249:16 amRNSTotal Voting Rights
23rd Aug 20243:18 pmRNSHolding(s) in Company
9th Aug 202410:08 amRNSHolding(s) in Company
5th Aug 20241:56 pmRNSDirector/PDMR Shareholding
2nd Aug 202411:51 amRNSDirector/PDMR Shareholding
1st Aug 20241:20 pmRNSDirector/PDMR Shareholding
31st Jul 202412:20 pmRNSTotal Voting Rights
5th Jul 20242:02 pmRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSQ3 Interim Management Statement
28th Jun 20249:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.